Kineticos consists of entrepreneurs, operators, and investors with successful exits.
Leveraging our expertise, network, ecosystem, and capital, Kineticos provides the most
relevant insights and recommendations for our portfolio companies, building value
every step of the way.
We partner with entrepreneurs and early-stage companies that offer unique, innovative, and IP-protected products and services with a focus on oncology, neurosciences, rare diseases, and antimicrobial resistance (AMR).
Learn MoreLeveraging our roots as a consultant, Kineticos can provide consulting services to portfolio companies. Capabilities include: